The Sarcoma Foundation of America (SFA) aims to advocate for sarcoma patients by funding research and increasing awareness about the disease. Through raising funds for sarcoma research and executing education and advocacy efforts, SFA strives to support patients affected by this condition.
The broad goal of the Sarcoma Foundation of America's grant program is to encourage research that enhances therapeutic options for sarcoma patients, contributing to the foundation's overarching aims by supporting studies across all areas of sarcoma research, including but not limited to, its etiology, molecular biology, pathogenesis, diagnosis, and treatment. This pursuit encompasses advocating for greater governmental funding against sarcoma, fostering partnerships with the biotechnology and pharmaceutical industries to expedite the development of novel and superior treatments, boosting public awareness about early detection, and providing education to sarcoma patients. The program offers up to $50,000 for one-year projects, with specific funding available for research on leiomyosarcoma and dedifferentiated liposarcoma. Budget allowances include a stipulation that up to 10% of the total cost may cater to indirect expenses, and no more than 50% can be allocated towards salaries for eligible roles within the research team.